The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer Commons’ virtual tumor board program: A patient-centric advisory panel and real-world data registry.
 
Lola Rahib
No Relationships to Disclose
 
David Kuang-Fu Chang
Speakers' Bureau - Celgene; Viatris
Research Funding - AstraZeneca (Inst); Celgene (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Celgene
 
Davendra Sohal
Honoraria - Foundation Medicine
Consulting or Advisory Role - Ability Pharma; Perthera
Speakers' Bureau - Incyte
Research Funding - Amgen (Inst); Apexigen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Rafael Pharmaceuticals (Inst)
 
Conan Grant Kinsey
No Relationships to Disclose
 
Deborah Christensen
No Relationships to Disclose
 
Mark Shapiro
Employment - xCures
Leadership - xCures
Stock and Other Ownership Interests - xCures
Consulting or Advisory Role - BioNTech; Marinus Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Various patents on software for AI-based clinical decision support technology.
 
Fatima Zelada-Arenas
No Relationships to Disclose
 
Andrew Scott Paulson
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Alexion Pharmaceuticals; Aptose Biosciences
Honoraria - Cardinal Health
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Bristol Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Pfizer; QED Therapeutics
Research Funding - AstraZeneca (Inst); bristol myers squibb (Inst); Deciphera (Inst); Exelixis (Inst); G1 Therapeutics (Inst); Hutchison MediPharma (Inst); incyte (Inst); Ipsen (Inst); Lilly (Inst); Taiho Pharmaceutical (Inst)
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Array BioPharma; AstraZeneca/MedImmune; Cancer Commons; Foundation Medicine; Ipsen; Legend Biotech
Research Funding - Agios (Inst); ArQule (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmuneSensor Therapeutics (Inst); MedImmune (Inst); Merck Serono (Inst); Sillajen (Inst); Tolero Pharmaceuticals (Inst)